The BMJ: leading general medical journal. Research. Education. Comment | The BMJ

Intended for healthcare professionals

People exercising

Research paper

Physical fitness training in patients with subacute stroke

Among adults with subacute stroke, aerobic bodyweight supported, treadmill based physical fitness training was not superior to relaxation sessions for improving activities of daily living

BMJ opinionNull but not void—the effectiveness of aerobic exercise following subacute stroke

chemotherapy cancer

Research paper

Design, risk of bias, and reporting of RCTs supporting approvals of cancer drugs by EMA

EditorialFlawed evidence underpins approval of new cancer drugs

BMJ opinionGauging the validity of cancer drug trials: a call for collaboration

ExternalStudy website including an interactive data repository

Phillip Morris cigarette advert

Feature

Foundation backed by Philip Morris funds schoolchildren’s global science contest

Joint hypermobility

Practice

Ehlers-Danlos syndromes

man vaping

Observations

Are e-cigarettes killing people in the US?

More articles

Feature

Gender dysphoria in children: puberty blockers study draws further criticism

News

Huge increase in hospital activity should be “wake-up call,” says acute medicine leader

News

Penalty system for free prescription claims must be “more humane,” say MPs

Editorial

Targeted health innovation for global health

News

Sertraline is better at reducing anxiety than depressive symptoms

News

Vaping among US teens has doubled since 2017

News

India bans e-cigarettes by executive order

News

Ophthalmologist who misled patients about treatment benefits is struck off

News

Sixty seconds on . . . cancer bells

BMJ opinionIt’s time to call time on “The end of treatment bell”

Minerva

Antibiotics and cancer? . . . and other stories

Endgames

An extensive perioral rash

Editor's choice

The miracle cure

Minerva

Ocular albinism

News

Seven days in medicine: 11-17 September 2019

News

Sixty seconds on . . . prostate testing

News

Half of trials supporting new cancer drug approval in Europe had high risk of bias

ResearchDesign characteristics, risk of bias, and reporting of RCTs supporting approvals of cancer drugs by EMA

Editorial

Flawed evidence underpins approval of new cancer drugs

ResearchDesign characteristics, risk of bias, and reporting of RCTs supporting approvals of cancer drugs by EMA

BMJ opinionGauging the validity of cancer drug trials: a call for collaboration

Views & reviews

David Oliver: £25m for hospices won’t go far

News

Toxicologists investigate cases of hand deformities in German babies

News

Vaccination uptake: access is still biggest barrier, experts warn

News

Cancer survivor swims channel four times non-stop

News

MPs call for inquiry into troubled urology unit after whistleblower publishes book

News

NHS England explores funding options for cystic fibrosis drug

Views & reviews

Matt Morgan: When bullet points miss the heart

Show more articles

Submit your paper

Editor's choice

Editor's choice

The miracle cure

The BMJ latest issue cover

Print and app issue

Promoting physical activity to patients | The BMJ

Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73) | The BMJ

I’ve noticed a change in my colleague’s behaviour. What should I do? | The BMJ

Unleash the power of patients to make care safer around the world: an essay by Helen Haskell | The BMJ

Acute vertigo | The BMJ

Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis | The BMJ